AAAAAA

   
Results: 1-10 |
Results: 10
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy
Authors: Kucuk, O Sarkar, FH Sakr, W Djuric, Z Pollak, MN Khachik, F Li, YW Banerjee, M Grignon, D Bertram, JS Crissman, JD Pontes, EJ Wood, DP
Citation: O. Kucuk et al., Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy, CANC EPID B, 10(8), 2001, pp. 861-868
Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms
Authors: Zarbo, RJ Barnes, L Crissman, JD Gnepp, DR Mills, SE
Citation: Rj. Zarbo et al., Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms, AM J CLIN P, 114(3), 2000, pp. 336-338
Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms
Authors: Zarbo, RJ Barnes, L Crissman, JD Gnepp, DR Mills, SE
Citation: Rj. Zarbo et al., Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms, VIRCHOWS AR, 437(4), 2000, pp. 345-347
Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms
Authors: Zarbo, RJ Barnes, L Crissman, JD Gnepp, DR Mills, SE
Citation: Rj. Zarbo et al., Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms, MOD PATHOL, 13(9), 2000, pp. 1038-1041
The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer - A Southwest Oncology Group Study
Authors: White, RWD Deitch, AD Daneshmand, S Blumenstein, B Lowe, BA Sagalowsky, AI Smith, JA Schellhammer, PF Stanisic, TH Grossman, HB Messing, E Crissman, JD Crawford, ED
Citation: Rwd. White et al., The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer - A Southwest Oncology Group Study, EUR UROL, 37(5), 2000, pp. 595-600
Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms (Reprinted)
Authors: Zarbo, RJ Barnes, L Crissman, JD Gnepp, DR Mills, SE
Citation: Rj. Zarbo et al., Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms (Reprinted), HUMAN PATH, 31(10), 2000, pp. 1191-1193
Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study
Authors: Lamm, DL Blumenstein, BA Crissman, JD Montie, JE Gottesman, JE Lowe, BA Sarosdy, MF Bohl, RD Grossman, HB Beck, TM Leimert, JT Crawford, ED
Citation: Dl. Lamm et al., Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study, J UROL, 163(4), 2000, pp. 1124-1129
A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studies
Authors: Li, L Zhu, ZY Joshi, B Zhang, C Johnson, CR Marnett, LJ Honn, KV Crissman, JD Porter, AT Tang, DG
Citation: L. Li et al., A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studies, ANTICANC R, 19(1A), 1999, pp. 61-69
Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade
Authors: Bianco, FJ Gervasi, DC Tiguert, R Grignon, DJ Pontes, JE Crissman, JD Fridman, R Wood, DP
Citation: Fj. Bianco et al., Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade, CLIN CANC R, 4(12), 1998, pp. 3011-3016
Histopathologic and flow-cytometric analysis of neoplastic and benign "background" tissue in breast carcinoma resections
Authors: Visscher, DW Gingrich, DS Leon-Armin, C Tabaczka, P Crissman, JD
Citation: Dw. Visscher et al., Histopathologic and flow-cytometric analysis of neoplastic and benign "background" tissue in breast carcinoma resections, ANAL CELL P, 17(3), 1998, pp. 167-175
Risultati: 1-10 |